Company intelligence / Profile preview

Intelligent Implants

Gothenburg, Sweden

Ownership: Private
Development stage: Other

Overview

Pre-clinical studies in sheep showed 3x more bone growth and cut fusion time by 50%. The device received FDA Breakthrough Device Designation based on these results. First human clinical study (15-20 patients) now starting.

Therapeutic areas: OtherNeurology
Modalities: DeviceElectrotherapeutic deviceElectronic implant
Industry: Implantable Medical Devices

Partnerships

Johnson & Johnson JLABS@TMC (incubator residency)SOSV HAX (accelerator/VC)SMAIAxiliumTB-Gruppen InvestSwedish angel investorsTMC Venture FundangelMD Catalyst Fund

Beyond the preview

Go deeper on Intelligent Implants.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intelligent Implants.

Explore the full profile